Belinostat (Beleodaq)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 17:54, 3 July 2014 by Jwarner (talk | contribs) (Created page with "==Mechanism of action== Histone deacetylase inhibitor ==Also known as== PXD101 ==History of changes in FDA indication== *7/3/2014: Granted accelerated approval for the treat...")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Histone deacetylase inhibitor

Also known as

PXD101

History of changes in FDA indication

7/3/2014: Granted accelerated approval for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

Retrieved from "https://hemonc.org/w/index.php?title=Belinostat_(Beleodaq)&oldid=4881"